Prognostic Impact of Lymphocyte-to-C-Reactive Protein Ratio in Patients Who Underwent Surgical Resection for Pancreatic Cancer

被引:3
作者
Iseda, Norifumi [1 ]
Iguchi, Tomohiro [1 ]
Hirose, Kosuke [1 ]
Itoh, Shinji [2 ,3 ]
Honboh, Takuya [1 ]
Sadanaga, Noriaki [1 ]
Matsuura, Hiroshi [1 ]
机构
[1] Saiseikai Fukuoka Gen Hosp, Dept Surg, 1-3-46 Tenjin Chuo Ku, Fukuoka, Fukuoka 8100001, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Surg, Fukuoka, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Sci, Fukuoka, Japan
关键词
pancreatic cancer; prognosis; lymphocyte-to-C-reactive protein ratio; systemic inflammation; SURVIVAL;
D O I
10.1177/00031348221117034
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Increasing evidence indicates that increased systemic inflammation is correlated with poorer cancer-specific survival in various cancer types. This study aimed to evaluate the prognostic value of various combinations of inflammatory factors in patients who underwent surgical resection for pancreatic cancer (PC). Methods We retrospectively analyzed 97 consecutive patients with PC who underwent pancreatectomy. We assessed the predictive impact for recurrence using a combination of 5 inflammatory markers and focused on the lymphocyte-C-reactive protein ratio (LCR) to elucidate its prognostic and predictive value for recurrence-free survival (RFS) and overall survival (OS) in univariate and multivariate analyses using the Cox proportional hazards model. Results Low preoperative LCR was correlated with low serum hemoglobin, low serum albumin concentration, high frequency of microscopic vascular invasion, and high frequency of microscopic perineural invasion. The low LCR group had significantly worse RFS and OS. Lower preoperative LCR was an independent predictor of shorter RFS and OS in this cohort. Discussion Preoperative LCR is a novel and convenient prognostic marker for patients with PC. Patients with low LCR may require more favorable intensive therapy.
引用
收藏
页码:4452 / 4458
页数:7
相关论文
共 24 条
[1]   Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer [J].
Allin, Kristine H. ;
Bojesen, Stig E. ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) :2217-2224
[2]   The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After [J].
Bassi, Claudio ;
Marchegiani, Giovanni ;
Dervenis, Christos ;
Sarr, Micheal ;
Abu Hilal, Mohammad ;
Adham, Mustapha ;
Allen, Peter ;
Andersson, Roland ;
Asbun, Horacio J. ;
Besselink, Marc G. ;
Conlon, Kevin ;
Del Chiaro, Marco ;
Falconi, Massimo ;
Fernandez-Cruz, Laureano ;
Fernandez-Del Castillo, Carlos ;
Fingerhut, Abe ;
Friess, Helmut ;
Gouma, Dirk J. ;
Hackert, Thilo ;
Izbicki, Jakob ;
Lillemoe, Keith D. ;
Neoptolemos, John P. ;
Olah, Attila ;
Schulick, Richard ;
Shrikhande, Shailesh V. ;
Takada, Tadahiro ;
Takaori, Kyoichi ;
Traverso, William ;
Vollmer, Charles ;
Wolfgang, Christopher L. ;
Yeo, Charles J. ;
Salvia, Roberto ;
Buehler, Marcus .
SURGERY, 2017, 161 (03) :584-591
[3]  
Brierley JD., 2017, TNM CLASSIFICATION M
[4]  
Clark E J, 2007, HPB (Oxford), V9, P456, DOI 10.1080/13651820701774891
[5]   FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer [J].
Conroy, T. ;
Hammel, P. ;
Hebbar, M. ;
Ben Abdelghani, M. ;
Wei, A. C. ;
Raoul, J. -L. ;
Chone, L. ;
Francois, E. ;
Artru, P. ;
Biagi, J. J. ;
Lecomte, T. ;
Assenat, E. ;
Faroux, R. ;
Ychou, M. ;
Volet, J. ;
Sauvanet, A. ;
Breysacher, G. ;
Di Fiore, F. ;
Cripps, C. ;
Kavan, P. ;
Texereau, P. ;
Bouhier-Leporrier, K. ;
Khemissa-Akouz, F. ;
Legoux, J. -L. ;
Juzyna, B. ;
Gourgou, S. ;
O'Callaghan, C. J. ;
Jouffroy-Zeller, C. ;
Rat, P. ;
Malka, D. ;
Castan, F. ;
Bachet, J. -B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2395-2406
[6]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[7]   The Prognostic Value of PLR in Lung Cancer, a Meta-analysis Based on Results from a Large Consecutive Cohort [J].
Ding, Nan ;
Pang, ZhaoFei ;
Shen, Hongchang ;
Ni, Yang ;
Du, Jiajun ;
Liu, Qi .
SCIENTIFIC REPORTS, 2016, 6
[8]   Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer [J].
Fan, Zhiyao ;
Luo, Guopei ;
Gong, Yitao ;
Xu, He ;
Qian, Yunzhen ;
Deng, Shengming ;
Huang, Qiuyi ;
Yang, Chao ;
Cheng, He ;
Jin, Kaizhou ;
Liu, Chen ;
Yu, Xianjun .
ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (10) :4017-4025
[9]   Immunity, Inflammation, and Cancer [J].
Grivennikov, Sergei I. ;
Greten, Florian R. ;
Karin, Michael .
CELL, 2010, 140 (06) :883-899
[10]   Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma [J].
Iseda, Norifumi ;
Itoh, Shinji ;
Yoshizumi, Tomoharu ;
Tomiyama, Takahiro ;
Morinaga, Akinari ;
Shimagaki, Tomonari ;
Wang, Huanlin ;
Kurihara, Takeshi ;
Toshima, Takeo ;
Nagao, Yoshihiro ;
Harada, Noboru ;
Oda, Yoshinao ;
Mori, Masaki .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (10) :1890-1900